Cargando…
Carotid dosimetry after re-irradiation with (131)Cs permanent implant brachytherapy in recurrent, resected head and neck cancer
PURPOSE: Permanent seed implant cesium-131 ((131)Cs) brachytherapy provides highly localized radiation for patients with recurrent head and neck cancer (HNC), who may be ineligible for external beam radiation therapy due to a high-risk of toxicity. As carotid blowout is a concern in the setting of r...
Autores principales: | Walsh, Amanda, Hubley, Emily, Doyle, Laura, Cognetti, David, Curry, Joseph, Bar-Ad, Voichita, Luginbuhl, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701389/ https://www.ncbi.nlm.nih.gov/pubmed/31447900 http://dx.doi.org/10.5114/jcb.2019.86298 |
Ejemplares similares
-
Single institution implementation of permanent (131)Cs interstitial brachytherapy for previously irradiated patients with resectable recurrent head and neck carcinoma
por: Bar-Ad, Voichita, et al.
Publicado: (2019) -
A nomogram to determine required seed air kerma strength in planar (131)Cesium permanent seed implant brachytherapy
por: Hubley, Emily, et al.
Publicado: (2019) -
Cesium-131 Interstitial Brachytherapy for Recurrent Malignancies of Skull Base
por: Savard, Corey, et al.
Publicado: (2019) -
A systematic review of treating recurrent head and neck cancer: a reintroduction of brachytherapy with or without surgery
por: Rodin, Julianna, et al.
Publicado: (2018) -
Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck Cancer
por: Luginbuhl, Adam, et al.
Publicado: (2021)